|
|
| səhifə | 14/16 | | tarix | 02.01.2022 | | ölçüsü | 151,52 Kb. | | #23474 |
| Nummer
|
Autor
|
Titel
|
V1.10
|
Frau Nafee, N.
|
Cationically modified PLGA nanoparticles for DNA/RNA delivery
|
V1.11
|
Herr Tätz, S.
|
Cationic chitosan/PLGA nanoparticles enhance the uptake of the antisense telomerase inhibitor 2’-O-Methyl-RNA into A549 lung cancer cells
|
V1.12
|
Frau Neubert, A.
|
Development of a Novel in Vitro-Dissolution Method for Drug-Eluting Stents
|
V1.13
|
Frau Wähling, C.
|
Gibt es Alternativen zum galenischen Ansatz, um die Löslichkeitskinetik von APIs zu verbessern?
|
V1.14
|
Herr Hugo, M.
|
Solid dispersion - Technik zur Verbesserung der Löslichkeitseigenschaften
|
V1.15
|
Frau Meister, E.
|
Freeze-Dry Microscopy: Investigation of interplay between physical properties of a formulation and collapse behaviour
|
V1.16
|
Frau Aderbauer, B.
|
Screening of medicinal plants from Mali for antitrypanosomal activity
|
V1.17
|
Frau Nolkemper, S.
|
Antivirale Wirkung wässriger Lamiaceen-Extrakte gegen Herpes Simplex Virus Typ 1 und Typ 2
|
V1.18
|
Frau Flügge, J.
|
Vitamin D receptor and colorectal cancer
|
V1.19
|
Herr Bulitta, J.
|
Video: Optimized prolonged infusion of beta-lactams with allometric dosing for cystic fibrosis patients
|
Dostları ilə paylaş: |
|
|
